Resmed board set to get new lead director
By HME News Staff
Updated 9:39 AM CDT, Tue August 18, 2026
SAN DIEGO – Resmed has announced that Carol Burt will become lead director on Nov. 15, 2026, succeeding Ron Taylor, who is not standing for re-election at the company’s 2026 Annual Meeting of Stockholders on Nov. 18 and will retire after more than 21 years of service to the company. Burt has served on Resmed’s board since 2013 and currently chairs the Nominating and Governance Committee. She is also a member of the Audit Committee and the Compliance, Privacy and Quality Committee. “Carol is an outstanding leader with deep governance experience, broad healthcare industry knowledge and a strong commitment to Resmed's mission,” said Mick Farrell, Resmed’s chairman and CEO. “I look forward to continuing to work closely with Carol and the entire board as we advance our strategy and create long-term value for our shareholders.” Taylor joined Resmed’s board in 2005 and has served in numerous leadership roles, including as lead director since 2013. During his tenure, he helped guide the company's governance, strategy and long-term growth while providing thoughtful leadership and independent oversight during a period of significant growth and transformation. “Ron has made extraordinary contributions to Resmed over the past two decades,” said Farrell. “His integrity, sound judgment and unwavering commitment to our patients, employees and shareholders have helped shape Resmed. On behalf of the Board and all Resmedians, I thank Ron for his outstanding service and wish him and his family all the very best.”
Comments